National Bank of Canada’s Invesco Pharmaceuticals ETF PJP Stock Holding History

National Bank of Canada’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.49K	Hold	24	–	–	﹤0.01%	2587
2025 Q4	$2.51K	Sell	24 -47	-66%	-$4.73K	﹤0.01%	2544
2025 Q3	$6.57K	Hold	71	–	–	﹤0.01%	2417
2025 Q2	$5.67K	Hold	71	–	–	﹤0.01%	2468
2025 Q1	$6.14K	Buy	71 +47	+196%	+$4K	﹤0.01%	2344
2024 Q4	$1.98K	Hold	24	–	–	﹤0.01%	2586
2024 Q3	$2.09K	Hold	24	–	–	﹤0.01%	2351
2024 Q2	$1.97K	Hold	24	–	–	﹤0.01%	2420
2024 Q1	$1.92K	Hold	24	–	–	﹤0.01%	2455
2023 Q4	$1.83K	Hold	24	–	–	﹤0.01%	2466
2023 Q3	$1.7K	Hold	24	–	–	﹤0.01%	2527
2023 Q2	$1.81K	Hold	24	–	–	﹤0.01%	2485
2023 Q1	$1.82K	Hold	24	–	–	﹤0.01%	2453
2022 Q4	$1.89K	Hold	24	–	–	﹤0.01%	2498
2022 Q3	$2K	Hold	24	–	–	﹤0.01%	2524
2022 Q2	$2K	Hold	24	–	–	﹤0.01%	2612
2022 Q1	$2K	Hold	24	–	–	﹤0.01%	2710
2021 Q4	$2K	Buy	+24	New	+$1.9K	﹤0.01%	2688

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada's PJP Position: Q1 2026 in Review

National Bank of Canada held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 24 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2587.

National Bank of Canada first reported a position in PJP in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.57K in Q3 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

National Bank of Canada held 24 shares of Invesco Pharmaceuticals ETF worth $2.49K as of Q1 2026.
National Bank of Canada left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2587 holding.
National Bank of Canada first reported a position in Invesco Pharmaceuticals ETF in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Invesco Pharmaceuticals ETF position peaked at $6.57K in Q3 2025.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.